Lewis, K. D., Samlowski, W., Ward, J., Catlett, J., Cranmer, L., Kirkwood, J., … Gonzalez, R. (2009). A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma. Investigational New Drugs, 29(1), 161–166. doi:10.1007/s10637-009-9333-6
